Insider Selling: Teladoc Health Inc (NYSE:TDOC) CEO Sells $6,561,300.00 in Stock

Teladoc Health Inc (NYSE:TDOC) CEO Jason N. Gorevic sold 30,000 shares of the stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $218.71, for a total transaction of $6,561,300.00. Following the sale, the chief executive officer now directly owns 697,283 shares in the company, valued at $152,502,764.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

NYSE:TDOC opened at $228.98 on Monday. Teladoc Health Inc has a twelve month low of $54.58 and a twelve month high of $230.40. The company has a current ratio of 6.14, a quick ratio of 6.14 and a debt-to-equity ratio of 0.45. The company has a 50-day moving average of $185.42 and a 200-day moving average of $144.40. The firm has a market cap of $17.05 billion, a price-to-earnings ratio of -169.61 and a beta of 0.44.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.35) by ($0.05). Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. The business had revenue of $180.80 million for the quarter, compared to the consensus estimate of $180.64 million. During the same quarter last year, the business posted ($0.43) EPS. The business’s revenue for the quarter was up 40.6% on a year-over-year basis. On average, research analysts forecast that Teladoc Health Inc will post -1.12 earnings per share for the current year.

Large investors have recently bought and sold shares of the company. Marshall Wace North America L.P. acquired a new position in shares of Teladoc Health in the first quarter worth about $35,000. Atria Investments LLC acquired a new position in shares of Teladoc Health in the fourth quarter worth about $379,000. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Teladoc Health by 6.5% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 22,490 shares of the health services provider’s stock worth $1,883,000 after buying an additional 1,366 shares during the period. ProShare Advisors LLC boosted its holdings in shares of Teladoc Health by 17.2% in the fourth quarter. ProShare Advisors LLC now owns 11,520 shares of the health services provider’s stock worth $964,000 after buying an additional 1,687 shares during the period. Finally, Renaissance Technologies LLC acquired a new position in shares of Teladoc Health in the fourth quarter worth about $45,435,000. Institutional investors own 97.66% of the company’s stock.

A number of analysts have weighed in on TDOC shares. Zacks Investment Research cut shares of Teladoc Health from a “buy” rating to a “hold” rating and set a $171.00 target price on the stock. in a report on Thursday, May 28th. SunTrust Banks increased their price objective on shares of Teladoc Health from $144.00 to $200.00 and gave the stock a “hold” rating in a report on Wednesday, May 13th. They noted that the move was a valuation call. Royal Bank of Canada reaffirmed a “buy” rating on shares of Teladoc Health in a report on Tuesday, June 30th. Craig Hallum increased their price objective on shares of Teladoc Health from $140.00 to $150.00 and gave the stock a “hold” rating in a report on Thursday, April 30th. Finally, Stephens started coverage on shares of Teladoc Health in a report on Monday, July 6th. They issued an “overweight” rating and a $250.00 price objective on the stock. Fifteen equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Teladoc Health currently has an average rating of “Hold” and an average price target of $166.32.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: Understanding the Price to Earnings Ratio (PE)

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.